These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31699206)

  • 1. [Leucine-rich Glioma-inactivated Protein 1 Antibody-associated Encephalitis:Report of Two Cases].
    Zhao JJ; Yang YH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):714-718. PubMed ID: 31699206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
    Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
    BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2.
    Murayama A; Sugaya K; Hara M; Kawazoe T; Tobisawa S; Nakajima H; Takahashi K
    Intern Med; 2023 Jun; 62(11):1659-1663. PubMed ID: 36223927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
    Li HY; Qiao S; Cui CS; Feng F; Liu XW; Yang XD
    J Clin Neurosci; 2022 Jul; 101():137-143. PubMed ID: 35597061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
    Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
    Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LGI1 antibody encephalitis and psychosis.
    Wang D; Hao Q; He L; Wang Q
    Australas Psychiatry; 2018 Dec; 26(6):612-614. PubMed ID: 29756462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
    Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
    Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
    Chen L; Su T; Liu Y
    BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.
    Naasan G; Irani SR; Bettcher BM; Geschwind MD; Gelfand JM
    JAMA Neurol; 2014 Oct; 71(10):1300-4. PubMed ID: 25133690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limbic encephalitis with LGI1 antibodies in a 14-year-old boy.
    Schimmel M; Frühwald MC; Bien CG
    Eur J Paediatr Neurol; 2018 Jan; 22(1):190-193. PubMed ID: 28919330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the clinical features of LGI1 antibody encephalitis.
    Zhao PP; Zhang Y; Gao L; Sun L
    Acta Neurol Belg; 2016 Mar; 116(1):109-12. PubMed ID: 26220774
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
    Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
    Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
    Hou L; Wan L; Li H; Wang Z; Guan H; Ren H; Wang P
    BMC Neurol; 2022 Jul; 22(1):281. PubMed ID: 35896991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unexplicated neuropsychiatric disorders: Do not ignore dysimmune encephalitis. A case report of a dysimmune encephalitis with anti-leucine rich glioma inactivated 1 (LGI-1) antibodies].
    Le Dault E; Lagarde S; Guedj E; Dufournet B; Rey C; Kaphan E; Tanguy G; Bregigeon M; Sagui E; Brosset C
    Rev Med Interne; 2016 Feb; 37(2):127-30. PubMed ID: 26164401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis.
    Casault C; Alikhani K; Pillay N; Koch M
    J Neuroimmunol; 2015 Dec; 289():84-6. PubMed ID: 26616875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides.
    Seery N; Butzkueven H; O'Brien TJ; Monif M
    Autoimmun Rev; 2022 May; 21(5):103074. PubMed ID: 35247644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report.
    Fujita H; Shioda M; Suzuki K
    BMC Neurol; 2022 Apr; 22(1):148. PubMed ID: 35448972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Patient with Limbic Encephalitis Associated with Anti-leucine-rich Glioma-inactivated 1 (LGI1) Antibody Presenting with Slowly Progressive Cognitive Impairment and Fluctuating Striatal Lesions.
    Sato M; Kishida D; Miyazaki D; Sekijima Y
    Intern Med; 2019 Jan; 58(2):287-291. PubMed ID: 30146575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.